Applicability of Lipoprotein (a) as a Risk Predictor for Cerebrovascular Disease

Journal Title: Scholars International Journal of Biochemistry - Year 2018, Vol 1, Issue 1

Abstract

Lipoprotein (a) is independently associated with Atherosclerotic Cardiovascular Disease (ASCVD) and is referred to as the most atherogenic lipoprotein. It is synergistic with the effects of low density lipoprotein cholesterol (LDL-C). Unlike other major classes of lipoproteins that have a normal distribution in the population, plasma levels of Lipoprotein (a) / Lp (a) have a skewed distribution towards the lower end with 85% population having concentration <30 mg/dL. The aim of present study is to estimate the level of serum Lp(a) in cerebrovascular diseases or Strokes. The study was conducted in the Department of Medicine, Department of Biochemistry, Sushila Tiwari Memorial Hospital, the teaching hospital of Uttaranchal Forest Hospital Trust (UFHT) Medical College, Haldwani (Nainital), Uttarakhand, on patients of cerebrovascular disease (CVD) which included estimation of Lp(a) and lipid profile (TC, TG, HDLc, LDLc, VLDLc) test. Out of the 17 women and 36 men in whom Lp (a) was measured, 2 women (mean age63.5 years) and 21 men (59years) had CVD (CVD(+), while 15 women (50.13 years) and 15 men (52.33 years) had no CVD [CVD(–)]. As shown in Table 1, there were no significant differences between women with or without CVD in age and concentration of total plasma cholesterol. The study was based on a small sized cohort of 23 cases suffering from (CVD) out of which 21 were males and 2 were females. Thirty (30) healthy subjects were taken as controls, who were not suffering from any disease, which may affect serum lipid levels and without any history of cerebrovascular disease. Total-C, LDLc, VLDLc, Triglyceride, HDLc, LDL/HDL, Cholesterol/HDL and Lp(a) were estimated in all the cases.

Authors and Affiliations

Sanjay Bhatt, V. S. singh, Sangeeta singh, S. R. Saxena, A. Joshi, Bindu Sati

Keywords

Related Articles

Enzymatic Exploration of Alcoholic Liver Disease

Alcoholic liver disease (ALD) is the most common liver disease in world. For many reasons, it is underestimated and underdiagnosed. Liver disease is the most likely diagnosis if the AST level is more than twice that of A...

Dyslipidemia in Type 2 Diabetic Patients

Type 2 diabetes mellitus has become a leading cause of morbidity and mortality world over. Insulin resistance plays a key role in the development of diabetic dyslipidemia, plasma lipid abnormalities contributes to the ri...

Effect of Specific Training Programme on Cholesterol among University Hockey Players

The purpose of the study was to find out the effect of specific training on cholesterol among university hockey players. To achieve this purpose of the study, thirty men hockey players were selected as subjects who were...

High Sensitivity-CRP in Diabetic Retinopathy Patients

Diabetic retinopathy is the most common cause of vision loss among people with diabetes and a leading cause of blindness among working age adults, it is a serious sight threatening complication of diabetes. Hs-CRP is a m...

Stress and Obesity in Health Professional Students: Myth or Reality

Background: Stress is a negative emotional, cognitive, behavioral and physiological process occurs as individual adjusts with stressors. Stress-induced eating may be one of the factors that leads to obesity due to increa...

Download PDF file
  • EP ID EP543133
  • DOI -
  • Views 94
  • Downloads 0

How To Cite

Sanjay Bhatt, V. S. singh, Sangeeta singh, S. R. Saxena, A. Joshi, Bindu Sati (2018). Applicability of Lipoprotein (a) as a Risk Predictor for Cerebrovascular Disease. Scholars International Journal of Biochemistry, 1(1), 9-13. https://europub.co.uk/articles/-A-543133